SEC Form 4 · accession 0001179110-18-004852
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Soldan
Officer — Exec VP, Operations
Period of report
Mar 23, 2018
Accepted (ET)
Mar 27, 2018 · 3:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2018 | M | 6,250 | $24.36 | A | 11,902 | D | |
| Common StockF2 | Mar 23, 2018 | S | 4,200 | $64.0007 | D | 7,702 | D | |
| Common StockF3 | Mar 23, 2018 | S | 1,500 | $64.8217 | D | 6,202 | D | |
| Common StockF4 | Mar 23, 2018 | S | 550 | $65.7845 | D | 5,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $24.36 | Mar 23, 2018 | M | 6,250 | D | — | Mar 23, 2026 | Common Stock | 6,250 | 12,500 | D |
| Stock Option (right to buy)F5 | $28.69 | holding | — | — | — | — | Aug 26, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.46 to $64.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2),(3) and (4) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.48 to $65.30,inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.67 to $65.93,inclusive.
- F5The option became exercisable as to 25,000 shares on August 26, 2017. The option becomes exercisable as to the remaining 50,000 shares in two equal installments of 25,000 on August 26, 2018 and 2019.
- F6The option became exercisable as to 6,250 shares on March 23, 2018. The option becomes exercisable as to the remaining 12,500 shares in two equal annual installments of 6,250 on March 23, 2019 and 2020.